Accueil Ernstrade Bourse Actualite Stock


Exchanges: Oslo

DiaGenic ASA is a Norway-based company principally  in the biotechnology sector. The Company’s activities include the research and development of patented technology for the early detection of Alzheimer's disease and breast cancer. Additionally, the Company is involved in the research and development of a Parkinson’s disease test. The Company’s products are blood-based gene expression tests, which distributed under the ADtect and BCtect names. The Company cooperates with such development partners as the Norwegian Radium Hospital, the Norwegian University for Life Sciences (UMB), the Ulleval University Hospital (UUS), the NKS Olaviken Psychogeriatric Hospital and the Mercy Women’s Center in Oklahoma, the United States, among others.
Grenseveien 92
Oslo, 0663
+47-23-248950 (Phone)
+47-23-248959 (Fax)


Copyright  2011